this product is applicable to moderate and severe infections caused by Streptococcus, Staphylococcus and anaerobic bacteria (including Bacteroides fragilis, Clostridium perfringens, actinomycetes, etc.), such as aspiration pneumonia, empyema, lung abscess, osteomyelitis, abdominal infection, pelvic infection and sepsis. It can be used for injection, capsule, ointment, gel, liniment and other formulations. It is suitable for the following infectious diseases caused by Gram positive bacteria and anaerobic bacteria, such as tonsillitis, suppurative otitis media, acute and chronic bronchitis, pneumonia, skin and soft tissue infection, urinary tract infection, female pelvic and genital infection, oral infection, etc. Osteomyelitis and infection after gynecological surgery.
IUPAC
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrate;hydrochloride